54503-20-7Relevant academic research and scientific papers
CuproCleav-1, a first generation photocage for Cu+
Mbatia, Hannah W.,Dhammika Bandara,Burdette, Shawn C.
supporting information; experimental part, p. 5331 - 5333 (2012/06/30)
By utilizing thioether ligands, CuproCleav-1 stabilizes Cu+ complexes in aqueous solution and releases the guest metal ion upon photolysis of the nitrobenzyl group. The photocage has an apparent Kd of 54 pM for Cu+, and metal ion release has been demonstrated using the fluorescent sensor CS1.
PYRROLINE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR, PREPARATION METHODS AND USES THEREOF
-
Page/Page column 11, (2009/08/14)
Compounds represented by Formula (I) or Formula (II) against cell releasing TNFα, their pharmaceutically acceptable salts or hydrates and preparation methods and uses thereof, in which A and B represent CH2, CO, SO, or SO2; D represents S, NH, or NC1-6 alkyl; R1 represents H, or one or two same or different radical(s) selected from the group consisting of F, Cl, Br, C1-4 alkyl,OH,OC1-4 alkyl,NO2,NHC(O)C1-4 alkyl,NH2,NH(C1-4 alkyl), or N(C1-4 alkyl)2.
Immunotherapeutic imides/amides
-
, (2008/06/13)
Imide/amide ethers and alcohols are inhibitors of cytokines including tumor necrosis factor α and can be used to combat cachexia, endotoxic shock, arthritis, asthma, and retrovirus replication. A typical embodiment is 3-Phthalimido-3-(3', 4'-dimethoxyphenyl)propan-1-ol.
